Sinphar Pharmaceutical Co (TPE:1734) Accounts Payable & Accrued Expense : NT$560 Mil (As of Mar. 2025)

View and export this data going back to 2002. Start your Free Trial

What is Sinphar Pharmaceutical Co Accounts Payable & Accrued Expense?

Sinphar Pharmaceutical Co's quarterly accounts payable & accrued expense declined from Sep. 2024 (NT$670 Mil) to Dec. 2024 (NT$561 Mil) and declined from Dec. 2024 (NT$561 Mil) to Mar. 2025 (NT$560 Mil).

Sinphar Pharmaceutical Co's annual accounts payable & accrued expense declined from Dec. 2022 (NT$795 Mil) to Dec. 2023 (NT$631 Mil) and declined from Dec. 2023 (NT$631 Mil) to Dec. 2024 (NT$561 Mil).

Sinphar Pharmaceutical Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sinphar Pharmaceutical Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinphar Pharmaceutical Co Accounts Payable & Accrued Expense Chart

Sinphar Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

555.35

756.55

795.01

630.80

561.36

Sinphar Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															612.20	789.33	669.67	561.36	559.92

Sinphar Pharmaceutical Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sinphar Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinphar Pharmaceutical Co Ltd (TPE:1734) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.84, Zhongshan Road, Dongshan Township, Zhongshan Village, Yilan, TWN, 269

Website

https://www.sinphar.com

Sinphar Pharmaceutical Co Ltd operates in the pharmaceutical segment. The company mainly engages in the production, processing, and trading of various Chinese medicines, medicinal cosmetics, and nutrients. The company's reportable segments are; Pharmaceuticals which derives key revenue, Healthy food, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from China, Vietnam, Indonesia, America, and other regions.

Sinphar Pharmaceutical Co Headlines

No Headlines